Global Aptamers Market By Type-(Nucleic Acid Aptamer, Peptide Aptamer)By Application-(Diagnostics, Therapeutics, Research and Development, Other Applications)By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2033

Market Overview

The Global Aptamers Market Size Is Expected To Be Worth Around USD 27.4 Billion By 2033 From USD 2.8 Billion In 2023, Growing At A CAGR Of 25.6 %.

Aptamers are oligonucleotide and peptide compounds that attach to the nucleic acid target proteins, lipids, and molecules that have a high degree of specificity. Aptamers can be formed as single-stranded loops or helices which allow them to adopt various forms. Aptamers that are produced rapidly are utilized to detect specific proteins, inhibit and characterisation of proteins. Aptamers can be utilized as functional proteomic levels using small molecules such as pharmaceutical leads, detection reagents and antibodies, as well as other Aptamers.

Aptamers have been gaining attention due to their many competitive advantages. These include recent advances in purification, production, drug delivery, and drug delivery to kill target cells. These advantages include a small molecular structure, low immunogenicity, and low manufacturing costs. They also have fewer side effects than antibodies. This could fuel market growth.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• Market Size & Growth: Global Aptamers Market Size Is Expected To Be Worth Around USD 27.4 Billion By 2033
• Type Analysis: The segment of nucleic acid held the largest market share of 76.4% in 2023
• Application Analysis: The segment for research and development had the largest percentage of market shares, which was 32.4% in 2023
• Regional Analysis: North America dominated aptamers in the 2023 market, accounting for 42.9% and holding a USD 832.2 Million
• Diagnostic Advancements: The incorporation of aptamers in biosensors and diagnostic tests offers advanced diagnostic capabilities. Aptamers facilitate rapid and accurate detection of specific biomarkers aiding in early diagnosis of disease.
• The global market presence: Aptamers Market is not limited to a particular region, it is a global market. Researchers and market participants worldwide are a part of the growth and advancement of technology based on aptamers.
• Research Diversification: Continual research is exploring the many applications of aptamers that go beyond diagnostics and therapeutics. Agriculture and environmental monitoring gain from the unique characteristics of aptamers, showing their potential for use in a variety of fields.

Type Analysis

Based on type, the aptamers market is divided into aptamers of nucleic acid and peptide Apotamers. The segment of nucleic acid held the largest market share of 76.4% in 2023 and is predicted to see the fastest increase over the forecast period.

Today, numerous companies are studying the mechanisms in the action of nucleic acid aptamers to treat different diseases, such as the degeneration of muscles caused by age. Additionally, the peptide aptamer segment is expected to see significant growth in the coming years due to its broad range of applications that can be used for diagnostic and therapeutic purposes.

The market’s largest segment was nucleic acids. This market is expected to see the most growth in the future. Numerous companies are studying the mechanism of action of nucleic acid aptamers for various disorders, such as age-related Macular Degeneration (AMD).

In 2023, the U.S. FDA approved a written agreement, under Special Protocol Assessment (SPA), for the design and execution of GATHER2 phase 3 to IVERIC BIO. A clinical trial of Zimura for patients with GA secondary AMD. This approval is expected to boost segment growth.

Because of its large user base for diagnostic and therapeutic purposes, the market for peptide-aptamers is expected to see significant growth. For example, the Engineering Center for Microtechnology and Diagnostics has developed a novel biosensor for multi-parametric expression testing in the preclinical diagnosis of cardiovascular disease.

Based on the molecular recognition and peptide aptamer markers system, next-generation biochips were developed for this purpose. Researchers used data from Protein 3D software and Data Bank to create peptide-aptamers. These products could help increase the usage of peptide Aptamers.

Application Analysis

Based on the application, the market for aptamers is divided into therapeutics, diagnostics research, and development as well as others. The segment for research and development had the largest percentage of market shares, which was 32.4% in 2023. The increase in this segment can be due to the increasing demand for aptamers, coupled with growing research efforts in this field. This has opened the door to aptamer demand in research and development.

The increasing research activity in this field has helped boost the demand for aptamers in the area of research and development. There are various strategic initiatives that are being taken by major market players, such as collaboration, partnerships and agreements to fund R&D of new aptamers-based diagnostic and therapeutic products.

In addition, the therapeutics market is expected to see the most rapid growth because of the capability to manufacture antidotes in a rational manner, and is believed to be a better option over protein-based therapeutics with regard to accessibility or modification as well as size. through medical chemical chemistry.

Collaborations, partnerships, and agreements are all keys to the R&D and development of new aptamers-based diagnostic and therapeutic products. Soma Logic Ltd. and Ixaka Ltd. established research collaboration in June 2023 with the goal of supporting the development and discovery of bispecific therapeutics using aptamers.

Due to its ability to rationally design antidotes, the therapeutics segment will experience significant market growth over the forecast period. These facts will all help the therapeutics sector to establish a strong market presence over the forecast period.

Key Market Segments

By Type

• Nucleic Acid Aptamer
• Peptide Aptamer

By Application

• Diagnostics
• Therapeutics
• Research and Development
• Other Applications

Drivers

Therapeutic Advancements

Therapeutic Advancements one major driver driving this Aptamers industry is their expanding use in therapeutic applications. Aptamers possess properties like high specificity to target as well as low immunogenicity and simple synthesis, making they a great candidate for the development of drug therapies and targeted treatments. Aptamers’ ability to bind to specific disease targets make them useful tools for precision medicine. They also contribute substantially to the growth of the market.

Trends

Diagnostic integration

A major trend driving the market for Aptamers includes their incorporation into diagnostic instruments. Aptamers are gaining applications in diagnostic tests and biosensors that allow for rapid and precise determination of biomarkers specific to with a variety of diseases. This trend is in line with the trend towards precise and personalized diagnostics, which emphasizes the significance of aptamers in developing diagnostic capabilities.

Restraints

Insufficient Market Awareness

While they are a great product one of the major obstacles on market acceptance for Aptamers industry is lack of knowledge within medical and scientific community. This lack of awareness impedes the wide acceptance of Aptamers. In order to overcome this challenge, we must make coordinated efforts in outreach and education to promote the unique advantages and uses of aptamers, which will allow them to reach their full market potential.

Opportunities

Diversification of Research Applications

A promising possibility lies in the widening of research applications that aptamers can be used for. Beyond the therapeutic and diagnostic applications the ongoing research is exploring the use of aptamers in a variety of areas such as agricultural and environmental monitoring. This broadens the market, opening new opportunities for market expansion.

Regional Analysis

North America dominated aptamers in the 2023 market, accounting for 42.9% and holding a USD 832.2 Million value for the Aptamers Market. The dominance of this region is due to the rising prevalence and strength of chronic diseases, as well as the growing interest in research laboratories in the area of aptamers.

The Asia Pacific is the region expected to experience the fastest growth during the forecast period. The approval of new aptamer-based products in the region is responsible for the region’s rapid growth. Achiko AG signed an agreement with Pengurus Wilayah Nahdlatul Ulama DKI in 2023. This is the largest Islamic association in Jakarta for the sales, marketing, and distribution of AptameX’s aptamer-based COVID-19 test kit AptameX.

*Actual Numbers Might Vary In The Final Report

Кеу Regions and Countries

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Players Analysis

Major players are adopting strategies for approval for new products, modifications to the product, mergers, and acquisitions. ProAxsis Limited and Aptamer Group formed a partnership in August 2023 for the development of optimal ligands to be used in the diagnostic assays developed by ProAxsis. Optimer ligands can be next-generation nucleic acids-based affinity aptamers.

Key Market Players

• Aptadel Therapeutics
• Base Pair Biotechnologies
• Noxxon Pharma
• Vivonics Inc.
• Aptagen, LLC
• TriLink Biotechnologies
• Altermune LLC
• AM Biotechnologies

Recent Development

• Diagnostic Technologies: Innovations in diagnostics include incorporation of aptamers in biosensors and tests. Research is focusing on increasing the sensitivity and precision of diagnostic instruments, including potential applications for early detection of diseases.
• Advanced Research Applications: Aptamer applications are expanding beyond diagnostics and therapeutics. Researchers are investigating aptamers in diverse research areas, like agricultural, environmental monitoring in addition to materials science. demonstrating the many applications of these molecules.
• Technology Improvements: Continuously improving methods for selecting aptamers including SELEX and advances in the synthesis and modification methods. Technology advancements are aimed at accelerating the design and development of aptamers that are specifically designed for certain applications.
• Industry Partnerships and Collaboration: Greater collaboration among biotechnology firms researchers, institutions of higher learning, along with pharmaceutical corporations. Partnerships aim to pool knowledge and resources to speed up the creation and commercialization of products based on aptamers.

Report Scope